What Are the Latest Treatments for Multiple Sclerosis?

Published: Dec 03, 2023

MS treatment is evolving rapidly, offering hope for better management of symptoms and progression. Dive into the latest therapies.
Contents

Disease-Modifying Therapies (DMTs)

DMTs are a cornerstone of MS treatment, aiming to reduce relapse rates and slow disease progression. These therapies have proven effective in managing relapsing forms of MS and are continuously being refined to enhance their efficacy.

Managing Symptoms

Beyond DMTs, managing MS symptoms like fatigue, pain, and mobility issues is crucial. This often involves a combination of medication, physical therapy, and lifestyle adjustments. Tailored treatment plans help patients maintain a higher quality of life.
Multiple Sclerosis (MS) is a chronic neurological condition characterized by the immune system attacking the protective covering of nerves, leading to communication problems between the brain and the rest of the body. Recent advances in treatment aim to reduce relapse rates and slow disease progression.

The Future of MS Treatment

Research is ongoing to discover new treatments and improve existing ones. Emerging therapies focus on neuroprotection and repair, aiming to halt or even reverse MS damage. These advancements offer hope for more comprehensive MS management in the future.

Frequently Asked Questions

DMTs are treatments that reduce MS relapses and slow progression.

Symptoms are managed through medication, therapy, and lifestyle changes.

Emerging therapies focus on neuroprotection and repair.

Research is exploring therapies that may reverse MS damage.

Treatment Insights

The future of MS treatment is promising, with ongoing advancements offering new hope.
Stay informed on MS treatment options with a consultation from Doctronic!

Related Articles

References

  1. University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, et al. Silent progression in disease activity-free relapsing multiple sclerosis. Ann Neurol 2019; 85:653.
  2. Amato MP, Fonderico M, Portaccio E, et al. Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis. Brain 2020; 143:3013.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely